59 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd.
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee … the Exchange Act, other than pursuant to the exercise of employee or director share options under the Company’s equity plans, the issuance of Ordinary
424B5
ENLV
Enlivex Therapeutics Ltd.
29 May 24
Prospectus supplement for primary offering
4:15pm
of a controlling shareholder who is an employee of the company, require the approval of the Compensation Committee, Board of Directors and, generally
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd.
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and the expected life of the award.
Employee benefits
The Company is required by Israeli law to make severance payments to Israeli employees upon … . A defined contribution plan is a program that benefits an employee after termination of employment, under which the Company regularly makes fixed payments
6-K
EX-99.1
x7txkt
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
zbaz3nbwr
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
dm2w58law1u 27h9lxdy
30 Dec 22
Prospectus supplement for primary offering
4:01pm
F-3
hfgdgu3cvx9asl
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
kpep5iwxe a3mr
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
S-8
5aiy boitzn8
4 Jun 21
Registration of securities for employees
4:16pm
6-K
EX-1.1
5764ei8b1t5m0fjxj
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
qtdjcf
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
l89e x0ptzp
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
4xa9fwiq
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-10.1
q11tcn2j9rgc0
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
ufk9elkl
22 Oct 20
Prospectus supplement for primary offering
8:45am